Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to assess the safety and effectiveness of
entecavir, when being added to lamivudine, in the treatment of adults with chronic hepatitis
B infection who are co-infected with HIV.